Science reports that a new study found mycophenolic acid has been driving resistance mutations in the fungal pathogen Pneumocystis jirovecii for almost two decades across outbreaks worldwide. The study’s description says the human-targeted drug selects for resistant strains that drive global transmission and outbreaks in transplant recipients.